PPARδ is the least explored isoform of the three PPARs but has great therapeutic potential for treatment of NASH/metabolic disease due to its role in regulating lipids, glucose homeostasis, and fatty acid synthesis [9]. The gene discussed is PPARD; the disease is metabolic dysfunction-associated steatohepatitis.